Events, workshops, info pills: find out more in PInK's video playlist.
Articles - Ca' Foscari News
Irene Scarpa and Nasier's success story is about innovative gels capable of removing various types of patina and restoring the beauty of every kind of artistic piece. It is, above all, a virtuous example of technology transfer from academia to business in the cultural heritage conservation area.
As part of the Res-Urbis project, Ca' Foscari researchers have patented a process to synthesize biodegradable polyester polymers from the organic fraction of domestic solid waste, effectively making a huge step forward towards an economy that wastes nothing.
Scientists from the Green Organic Synthesis Team (GOST) research team led by Alvise Perosa and Maurizio Selva from Ca’ Foscari University of Venice have demonstrated for the first time the possibility of triggering chemical reactions by illuminating natural carbon nanoparticles.
Thanks to an antiviral molecule of plant origin, both long-lasting and non-toxic to humans, Ca' Foscari and Delphinus Biotech have developed a disinfectant that can eliminate bacteria and viruses, while also providing active protection for several days.
A research group at Ca’ Foscari, led by Claudia Crestini, has discovered and patented a method that transforms lignin into a commodity based on high value-added materials.
Between Venice and Sweden, professor Vomiero supervises a team of scientists in the search for structured nanocomposites for the production of renewable energy.
Ca’ Foscari is the only research institution in Italy to be selected for the “Marie Skłodowska-Curie - COFUND” project, a prestigious grant that will help the university hire 15 expert researchers from all over the world to tackle important global challenges.
Experimenting a targeted therapy innovative for ovarian cancer and developing a new drug for leiomyosarcoma are the ambitious objectives of two projects at the Ca' Foscari University of Venice, which will be supported by the AIRC Foundation.
The invention, jointly patented by the Ca' Foscari University and the IRCCS Cancer Institute in Aviano, will make it possible to optimise the doses administered according to the patient's response, limiting side effects and improving therapy.